The Intersection of Premenstrual Syndrome (PMS) and Mood Disorders: A Narrative Review
DOI:
https://doi.org/10.12775/QS.2025.39.58489Keywords
Premenstrual Syndrome, Mood Disorders, Depression, Anxiety, Hormonal Fluctuations, Neurotransmitters, Cultural PerspectivesAbstract
Premenstrual Syndrome (PMS) encompasses a range of physical, emotional, and behavioral symptoms occurring cyclically during the luteal phase of the menstrual cycle. Mood disorders such as depression and anxiety often overlap with PMS, suggesting shared pathophysiological mechanisms. This narrative review explores the hormonal, neurochemical, psychosocial, and cultural factors contributing to the comorbidity of PMS and mood disorders. Understanding these interactions can guide effective diagnostic approaches and individualized treatment strategies.
References
Yonkers, K. A., O'Brien, P. M. S., & Eriksson, E. (2008). Premenstrual syndrome. The Lancet, 371(9619), 1200–1210.
Freeman, E. W., et al. (2001). Premenstrual syndrome: recognition and treatment. Journal of Clinical Psychiatry, 62(6), 432–438.
Kim, D. R., Gyulai, L., Freeman, E. W., Morrison, M. F., & Baldassano, C. (2004). Premenstrual dysphoric disorder and psychiatric co-morbidity. Archives of Women's Mental Health, 7(1), 37–47.
Kaufman, J., & Charney, D. (2000). Comorbidity of mood and anxiety disorders. Depression and Anxiety, 12(Suppl 1), 69–76. doi:10.1002/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K. PMID: 11098417.
Facchinetti, F., Sances, G., Borella, P., Genazzani, A. R., & Nappi, G. (2003). Magnesium prophylaxis of menstrual migraine: Effects on intracellular magnesium. Headache: The Journal of Head and Face Pain, 43(7), 596–602.
Rapkin, A. J., & Lewis, E. I. (2013). Treatment of premenstrual dysphoric disorder. Women's Health (London), 9(6), 537–556.
Halbreich, U., & Kahn, L. S. (2001). Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs, 15(10), 797–817.
Schmidt, P. J., et al. (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. New England Journal of Medicine, 338(4), 209–216.
Epperson, C. N., et al. (2002). Cortical γ-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: relationship to progesterone. The Journal of Clinical Endocrinology & Metabolism, 87(12), 5556–5560.
Hantsoo, L., & Epperson, C. N. (2020). Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiology of Stress, 12, 100213. doi:10.1016/j.ynstr.2020.100213.
Freeman EW, Rickels K, Arredondo F, Kao LC, Pollack SE, Sondheimer SJ. Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant. J Clin Psychopharmacol. 1999 Feb;19(1):3-8.
Peroutka SJ. Dopamine and migraine. Neurology. 1997 Sep;49(3):650-6.
Girdler, S. S., & Klatzkin, R. (2007). Biological mechanisms underlying the relationship between PMS and stress: preliminary data. Current Psychiatry Reports, 9(6), 467–475.
Amin, F. M., & Ashina, M. (2012). Hormone-related headache: Pathophysiology and clinical implications. Current Opinion in Neurology, 25(3), 241–246.
Edvinsson, L., & Uddman, R. (2005). Neurobiology in primary headaches. Brain Research Reviews, 48(3), 438–456.
Freeman, E. W., Rickels, K., Arredondo, F., Kao, L. C., Pollack, S. E., & Sondheimer, S. J. (1999). Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant. Journal of Clinical Psychopharmacology, 19(1), 3–8.
Elrington, G. (2002). Migraine: Diagnosis and management. Journal of Neurology, Neurosurgery & Psychiatry, 72(Suppl 2), ii10–ii15. PMID: 12122196; PMCID: PMC1765586
Calhoun, A. H., & Hutchinson, S. (2009). Hormonal therapies for menstrual migraine. Current Pain and Headache Reports, 13(5), 381–385.
Sances, G., Allais, G., Benedetto, C., et al. (2004). Estrogen levels and menstrual migraine: A study on a population of migraine sufferers. Headache, 44(9), 930–934.
Holroyd, K. A., Cottrell, C. K., O’Donnell, F. J., et al. (2010). Effect of cognitive-behavioral therapy on headaches in adolescents: A randomized controlled trial. JAMA, 304(18), 1935–1943.
Rains, J. C., Penzien, D. B., & Lipchik, G. L. (2005). Behavioral treatment of chronic headache: Outcome and process. Headache, 45(5), 561–570.
Wells, R. E., O’Connell, N. E., Pierce, C. R., et al. (2014). Effectiveness of mindfulness meditation plus amitriptyline compared with amitriptyline alone for migraine prevention: A randomized clinical trial. JAMA Internal Medicine, 174(4), 468–477.
Facchinetti, F., Borella, P., Sances, G., Genazzani, A. R., & Nappi, G. (1991). Magnesium prophylaxis of menstrual migraine: Effects on intracellular magnesium. Headache, 31(5), 298–301.
Charles, A. (2018). The pathophysiology of migraine: Implications for clinical management. The Lancet Neurology, 17(2), 174–182.
Nappi, R. E., Sances, G., & Facchinetti, F. (2013). Hormonal aspects of migraine and their therapeutic implications. Expert Review of Neurotherapeutics, 13(4), 421–432.
Genazzani, A. R., Stomati, M., Bernardi, F., et al. (2010). Hormonal fluctuations and neurochemical changes: Their role in mood disorders. Menopause International, 16(4), 141–146.
MacGregor, E. A. (2014). Estrogen and attacks of migraine with and without aura. The Lancet Neurology, 13(4), 303–313.
Mateen, S., Zafar, A., Moin, S., Khan, A. Q., & Zubair, S. (2016). Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clinica Chimica Acta, 455, 161–171. PMID: 26883280
Maizels, M., & Burchette, R. (2004). Somatic symptoms in headache patients: Influence of migraine and depression. Headache: The Journal of Head and Face Pain, 44(9), 974–982.
Breslau, N., Lipton, R. B., Stewart, W. F., Schultz, L. R., & Welch, K. M. A. (2003). Comorbidity of migraine and depression: Investigating potential etiology and prognosis. Neurology, 60(8), 1308–1312.
Fuh, J. L., Wang, S. J., Lu, S. R., & Juang, K. D. (2007). Comorbid migraine, major depression, and anxiety disorders in adolescents. Neurology, 68(6), 419–424.
Liu, Q., Wang, Y., van Heck, C. H., & Qiao, W. (2017). Stress reactivity and emotion in premenstrual syndrome. Neuropsychiatric Disease and Treatment, 13, 1597–1602.
Wittchen, H.-U., Becker, E., Lieb, R., & Krause, P. (2002). Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychological Medicine, 32(1), 119-132.
Pearlstein, T., & Steiner, M. (2008). Premenstrual dysphoric disorder: burden of illness and treatment update. Journal of Psychiatry & Neuroscience, 33(4), 291–301.
Marjoribanks, J., Brown, J., O'Brien, P. M., & Wyatt, K. (2013). Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews, 2013(6), CD001396.
Sundström, I., Bäckström, T., Wang, M., Olsson, T., Seippel, L., & Bixo, M. (1999). Premenstrual syndrome, neuroactive steroids and the brain. Gynecological Endocrinology, 13(3), 206-220.
Lustyk, M. K., Widman, L., Paschane, A., & Ecker, E. (2004). Stress, quality of life and physical activity in women with varying degrees of premenstrual symptomatology. Women & Health, 39(3), 35–44.
Steiner, M., Macdougall, M., & Brown, E. (2003). The premenstrual symptoms screening tool (PSST) for clinicians. Archives of Women's Mental Health, 6(3), 203-209.
King, S. (2020). Premenstrual Syndrome (PMS) and the Myth of the Irrational Female. In: The Palgrave Handbook of Critical Menstruation Studies.
Buse, D. C., Greisman, J. D., Baigi, K., & Lipton, R. B. (2013). Migraine Progression: A Systematic Review. Headache: The Journal of Head and Face Pain, 53(4), 661–676.
Calhoun, A. H., & Hutchinson, S. (2009). Hormonal therapies for menstrual migraine. Current Pain and Headache Reports, 13(5), 381–385.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Michalina Makieła, Stanisław Dudek, Weronika Koziak , Aleksandra Bętkowska, Agata Kornacka, Kamila Szostak, Rafał Tomaka, Wojciech Dudek, Anna Byra, Marta Makieła
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 373
Number of citations: 0
